‘Extreme Outlier’ Vertex Slammed For Orkambi Pricing Approach In England

 
• By Francesca Bruce

Vertex has come under fire for its alleged extreme rigidity on pricing for its cystic fibrosis drug in England.

Cystic fibrosis word cloud
Vertex Is Under Scrutiny For Its Cystic Fibrosis Drug Prices

More from Europe

More from Geography